Kyung Dong Pharmaceutical Co., Ltd. (KOSDAQ:011040)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,080.00
-50.00 (-0.97%)
At close: Sep 11, 2026

Kyung Dong Pharmaceutical Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
201,120196,273193,936162,674182,718177,611
Revenue Growth
3.46%1.21%19.22%-10.97%2.88%2.18%
Gross Profit
122,115117,101114,36589,34495,91098,082
Operating Income
11,7727,6662,624-24,9558,31215,758
Net Income
17,8318,5295,470-20,70812,16112,672
Earnings Per Share
647.85315.00203.00-763.17446.96460.42
EPS Growth
330.83%55.17%---2.92%-9.33%

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
27,68146,99830,91332,07545,12850,043
Total Debt
25,69245,44338,67715,37326,8694,329
Net Cash (Debt)
1,9891,554-7,76416,70118,25945,714
Net Cash Growth
----8.53%-60.06%-23.28%
Net Cash Per Share
72.1757.28-288.15615.52671.071660.97

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
20,66516,934-8,074-31.94-1,07512,422
Capital Expenditures
-16,059-18,394-7,618-6,290-10,574-3,926
Free Cash Flow
4,606-1,460-15,692-6,322-11,6498,496
Free Cash Flow Growth
-55.00%-----

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
60.72%59.66%58.97%54.92%52.49%55.22%
Operating Margin
5.85%3.91%1.35%-15.34%4.55%8.87%
Pretax Margin
10.56%4.65%2.69%-11.37%9.82%10.38%
Profit Margin
8.87%4.35%2.82%-12.73%6.66%7.13%
FCF Margin
2.29%-0.74%-8.09%-3.89%-6.38%4.78%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
300.000---400.000500.000
Dividend Per Share Growth
0%----20.00%0%
Dividend Yield
5.88%---5.96%5.38%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
7.8418.4530.19-17.5624.74
Forward PE
-12.1112.1112.1112.1112.11
P/FCF Ratio
32.32----36.90
PS Ratio
0.740.800.851.101.171.77